John R. Stille

2.8k total citations
56 papers, 1.7k citations indexed

About

John R. Stille is a scholar working on Organic Chemistry, Oncology and Molecular Biology. According to data from OpenAlex, John R. Stille has authored 56 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Organic Chemistry, 15 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in John R. Stille's work include Asymmetric Synthesis and Catalysis (11 papers), Lung Cancer Research Studies (7 papers) and Chemical synthesis and alkaloids (7 papers). John R. Stille is often cited by papers focused on Asymmetric Synthesis and Catalysis (11 papers), Lung Cancer Research Studies (7 papers) and Chemical synthesis and alkaloids (7 papers). John R. Stille collaborates with scholars based in United States, Canada and Belgium. John R. Stille's co-authors include Robert H. Grubbs, K. Paulvannan, Gregory R. Cook, Nancy S. Barta, Bernard D. Santarsiero, Jonathan R. Young, J. K. Stille, John Polzer, Gregory L. Baker and Scott J. Fritschel and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Nature Reviews Drug Discovery.

In The Last Decade

John R. Stille

55 papers receiving 1.7k citations

Peers

John R. Stille
Joel C. Barrish United States
Timothy D. Owens United States
Charles L. Cywin United States
Atli Thorarensen United States
John D. Chisholm United States
Mark G. Saulnier United States
Jiancun Zhang China
Alexandre A. Pletnev United States
Siavosh Mahboobi Germany
Michael J. Grogan United States
Joel C. Barrish United States
John R. Stille
Citations per year, relative to John R. Stille John R. Stille (= 1×) peers Joel C. Barrish

Countries citing papers authored by John R. Stille

Since Specialization
Citations

This map shows the geographic impact of John R. Stille's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Stille with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Stille more than expected).

Fields of papers citing papers by John R. Stille

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Stille. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Stille. The network helps show where John R. Stille may publish in the future.

Co-authorship network of co-authors of John R. Stille

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Stille. A scholar is included among the top collaborators of John R. Stille based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Stille. John R. Stille is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chu, Quincy S., Nathaniel Bouganim, Sara Zaknoen, et al.. (2021). Aurora kinase A inhibitor, LY3295668 erbumine: a phase 1 monotherapy safety study in patients with locally advanced or metastatic solid tumors. Investigational New Drugs. 39(4). 1001–1010. 19 indexed citations
2.
Robertson-Plouch, Carol, John R. Stille, Peng Liu, et al.. (2019). A randomized clinical efficacy study targeting mPGES1 or EP4 in dogs with spontaneous osteoarthritis. Science Translational Medicine. 11(516). 13 indexed citations
3.
Yuen, Eunice, Yu‐Hua Hui, Amparo de la Peña, et al.. (2019). Abstract CT019: Population pharmacokinetics of an aurora kinase A inhibitor, LY3295668 erbumine (AK-01), in patients with locally advanced or metastatic solid tumors. Cancer Research. 79(13_Supplement). CT019–CT019.
4.
5.
Salgia, Ravi, John R. Stille, Michael McCleod, et al.. (2017). A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive‐disease small cell lung cancer. Lung Cancer. 105. 7–13. 55 indexed citations
6.
Hainsworth, John D., James A. Reeves, Joseph R. Mace, et al.. (2016). A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC). Targeted Oncology. 11(5). 643–653. 54 indexed citations
7.
Owens, Paul K., et al.. (2014). A decade of innovation in pharmaceutical R&D: the Chorus model. Nature Reviews Drug Discovery. 14(1). 17–28. 48 indexed citations
8.
Spigel, David R., Michael McCleod, Oday Hamid, et al.. (2014). Phase Ii Study of Carboplatin/Etoposide Plus Ly2510924, a Cxcr4 Peptide Antagonist, Versus Carboplatin/Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer (Sclc). Annals of Oncology. 25. iv514–iv514. 2 indexed citations
9.
Ward, Donald L., et al.. (1997). Formation of Dihydropyridone- and Pyridone-Based Peptide Analogs through Aza-Annulation of β-Enamino Ester and Amide Substrates with α-Amido Acrylate Derivatives. The Journal of Organic Chemistry. 62(4). 1033–1042. 75 indexed citations
10.
Barta, Nancy S., Brian A. Kirk, & John R. Stille. (1995). Competitive intramolecular TiC versus AlC alkene insertions: Examining the role of Lewis acid cocatalysts in Ziegler-Natta alkene insertion and chain transfer reactions. Journal of Organometallic Chemistry. 487(1-2). 47–53. 5 indexed citations
11.
12.
13.
Cook, Gregory R., et al.. (1994). Construction of Hydroxylated Alkaloids (.+-.)-Mannonolactam, (.+-.)-Deoxymannojirimycin, and (.+-.)-Prosopinine through Aza-Annulation. The Journal of Organic Chemistry. 59(13). 3575–3584. 102 indexed citations
14.
Barta, Nancy S., et al.. (1994). Asymmetric Formation of Quaternary Centers through Aza-Annulation of Chiral .beta.-Enamino Esters with Acrylate Derivatives. Journal of the American Chemical Society. 116(14). 6201–6206. 42 indexed citations
15.
Paulvannan, K. & John R. Stille. (1993). Decahydroquinoline construction through aza-annulation: A stereoselective synthesis of (±)-5-epipumiliotoxin C.. Tetrahedron Letters. 34(42). 6673–6676. 23 indexed citations
16.
Cook, Gregory R., Nancy S. Barta, & John R. Stille. (1992). Lewis acid-promoted 3-aza-Cope rearrangement of N-alkyl-N-allyl enamines. The Journal of Organic Chemistry. 57(2). 461–467. 22 indexed citations
17.
Young, Jonathan R. & John R. Stille. (1990). Stereoselective formation of dimethylcyclopentanes through intramolecular Ziegler-Natta alkene insertion. Organometallics. 9(12). 3022–3025. 22 indexed citations
18.
Stille, John R., Bernard D. Santarsiero, & Robert H. Grubbs. (1990). Rearrangement of bicyclo[2.2.1]heptane ring systems by titanocene alkylidene complexes to bicyclo[3.2.0]heptane enol ethers. Total synthesis of (.+-.)-.DELTA.9(12)-capnellene. The Journal of Organic Chemistry. 55(3). 843–862. 91 indexed citations
19.
Cannizzo, Louis F., et al.. (1983). Cp2TiCH2 complexes in synthetic applications. Pure and Applied Chemistry. 55(11). 1733–1744. 123 indexed citations
20.
Stille, John R. & Robert H. Grubbs. (1983). Synthetic applications of titanocene methylene complexes: selective formation of ketone enolates and their reactions. Journal of the American Chemical Society. 105(6). 1664–1665. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joel C. Barrish Breakdown of academic impact, for papers by Timothy D. Owens Breakdown of academic impact, for papers by Charles L. Cywin Breakdown of academic impact, for papers by Atli Thorarensen Breakdown of academic impact, for papers by John D. Chisholm Breakdown of academic impact, for papers by Mark G. Saulnier Breakdown of academic impact, for papers by Jiancun Zhang Breakdown of academic impact, for papers by Alexandre A. Pletnev Breakdown of academic impact, for papers by Siavosh Mahboobi Breakdown of academic impact, for papers by Michael J. Grogan
Rankless by CCL
2026